To begin investigating how RT was enabling anti-tumor responses to CpG+OX40, we measured gene expression changes within the TME of B78 tumors 14 days after treatment when group tumor volumes began to show differences between mice treated with RT+CpG+OX40 and the three other groups. This evidence concerns the gene TNFRSF4 and neoplasm.